Clinical Trial Update: AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of AB-2004 for irritability in autism spectrum disorder has completed; the update summarizes the study results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• AB-2004

Snippet

Sponsor: Vertero Therapeutics | Conditions: Autism Spectrum Disorder (ASD) | Phase 2 | Status: COMPLETED